How a Single Mutation Rewires Brain Proteins to Trigger Parkinson's Disease
A deep proteomics study reveals how the D620N mutation in VPS35 subtly disrupts key brain protein interactions, shedding light on retromer dysfunction in Parkinson's disease.
Summary
Parkinson's disease can be caused by mutations in the VPS35 gene, which encodes a key component of the retromer complex — a cellular sorting system that recycles proteins inside neurons. The D620N mutation is linked to late-onset, inherited Parkinson's, but exactly how it causes neurodegeneration has been unclear. Researchers at the Van Andel Institute used advanced proteomics techniques in cell lines, rat brains, and genetically engineered mice to map VPS35's full protein interaction network and compare how the D620N mutation changes it. They found the mutation has a surprisingly subtle overall effect, but selectively weakens VPS35's interactions with two key proteins — TBC1D5 and VPS29 — in both brain regions studied. These disrupted interactions may impair retromer function and contribute to neuronal loss in Parkinson's.
Detailed Summary
Parkinson's disease (PD) affects millions of aging adults worldwide, and understanding its molecular underpinnings is critical for developing effective treatments. Among the genetic causes of PD, mutations in the VPS35 gene stand out because VPS35 is a core subunit of the retromer complex — a cellular machinery responsible for sorting and recycling proteins at the endosome. The D620N mutation in VPS35 causes a late-onset, autosomal dominant form of PD, but the precise mechanism linking this mutation to neurodegeneration has remained elusive.
Researchers at the Van Andel Institute employed state-of-the-art interactome proteomics to comprehensively map the protein interaction networks of both wild-type and D620N VPS35. Using tandem affinity purification and co-immunoprecipitation with chemical crosslinking in HEK-293T cells, they identified both native and non-native protein interactors. Importantly, they also performed the first characterization of VPS35's brain-specific protein interactome, using a viral gene transfer model in adult rats and a D620N knockin mouse model expressing VPS35 at physiological levels.
Across all models, the D620N mutation produced a strikingly similar overall interactome compared to wild-type VPS35, suggesting its effects are subtle rather than globally disruptive. However, two specific protein interactions were consistently and selectively reduced: those with TBC1D5, a Rab GTPase-activating protein, and VPS29, another retromer subunit. Reduced interaction with WASH complex components was also confirmed, consistent with prior reports.
These selective disruptions provide a refined mechanistic picture of how D620N VPS35 impairs retromer function without wholesale dismantling the complex. The loss of TBC1D5 and VPS29 interactions may compromise endosomal trafficking in neurons, potentially leading to the accumulation of pathogenic proteins over time.
For the aging brain, these findings are directly relevant: retromer dysfunction has been implicated not only in familial PD but also in sporadic Alzheimer's disease. Targeting VPS35 interactions — particularly VPS29 and TBC1D5 — may represent a therapeutic strategy for preserving neuronal health in aging. Caveats include that the summary is based on the abstract only, and most models used overexpression, which may not perfectly recapitulate endogenous biology.
Key Findings
- D620N VPS35 mutation selectively reduces interactions with TBC1D5 and VPS29 in both hemibrain and striatum of knockin mice.
- Overall brain protein interactome of D620N VPS35 is surprisingly similar to wild-type, indicating subtle rather than global disruption.
- First brain-specific VPS35 protein interactome was mapped using a viral gene transfer model in adult rat brain.
- Reduced VPS35 interaction with WASH complex components was confirmed across cell and brain models.
- Global proteomic analysis of striatal tissue showed high similarity between wild-type and D620N mice, pointing to selective rather than widespread proteome changes.
Methodology
The study used tandem affinity purification and co-immunoprecipitation with chemical crosslinking in HEK-293T cells, viral-mediated gene transfer in adult rat brain, and a D620N VPS35 knockin mouse model expressing the mutation at endogenous levels. Proteomics was performed on hemibrain and striatal tissue from knockin mice, alongside global proteomic profiling of striatal tissue to assess broader protein-level changes.
Study Limitations
This summary is based on the abstract only, as the full text was not accessible. Most cell-based experiments used overexpression models, which may not fully reflect endogenous protein dynamics. The knockin mouse model addresses this to some extent, but translation to human brain pathology requires further validation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: